Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline.
about
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer's disease.The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
P2860
Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Value of FDG-PET scans of non- ...... nitive and functional decline.
@en
type
label
Value of FDG-PET scans of non- ...... nitive and functional decline.
@en
prefLabel
Value of FDG-PET scans of non- ...... nitive and functional decline.
@en
P2093
P2860
P1476
Value of FDG-PET scans of non- ...... nitive and functional decline.
@en
P2093
Alzheimer’sDisease Neuroimaging Initiative
Daniel H S Silverman
Kelsey Mason
Magnus Dahlbom
Nare Torosyan
P2860
P2888
P304
P356
10.1007/S00259-017-3634-3
P577
2017-03-22T00:00:00Z